Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Plos Biology|February 4, 2017
Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewJames Mattina, Benjamin Carlisle, Yasmina Hachem, et al.BMJ Supportive & Palliative Care|May 2, 2023
Medical cannabis is effective for cancer-related pain: Quebec Cannabis Registry resultsSaro Aprikian, Popi Kasvis, MariaLuisa Vigano, et al.BMC Complementary Medicine and Therapies|September 8, 2022
Healthcare practitioner perceptions on barriers impacting cannabis prescribing practicesYasmina Hachem, Sara J Abdallah, Sergio Rueda, et al.Drug Safety|November 23, 2023
A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis RegistryYasmina Hachem, Yola Moride, Anne-Marie Castilloux, et al.Plos One|February 8, 2022
Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trialsDaniel M Benjamin, Spencer P Hey, Amanda MacPherson, et al.Cannabis and Cannabinoid Research|December 29, 2022
The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical CannabisAntonio Vigano, Yola Moride, Yasmina Hachem, et al.Journal of Pain and Symptom Management|November 7, 2024
Electronic Health Record Serious Illness Conversation Dashboards: An Implementation Case SeriesYasmina Hachem, Joshua Lakin, Winifred Teuteberg, et al.Genes & Development|January 30, 2019
Afadin cooperates with Claudin-2 to promote breast cancer metastasisSébastien Tabariès, Alexander McNulty, Véronique Ouellet, et al.Arthritis Care & Research|July 25, 2022
Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort StudyRomina Sotoodeh, Lilach Eyal Waldman, Antonio Vigano, et al.Communications Biology|June 3, 2021
Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth patternSébastien Tabariès, Matthew G Annis, Anthoula Lazaris, et al.Pageof 1